03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Iclusig 45mg² : | |
Type | Medicine Authorised |
Originator | B |
Agent | Droguerie de l'Union |
Distributor | Droguerie de l'Union |
Laboratory | Takeda |
Responsible Party | Takeda Pharmaceuticals USA Inc |
Origin | U.S.A. |
Manufacturer | Takeda Pharmaceuticals USA Inc |
Origin | Canada |
ATC | L01XE24 |
Iclusig 45mg² :
Iclusig 45mg² :
Iclusig 45mg² :
Iclusig 45mg² :
Iclusig 45mg² :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Iclusig 45mg² :
Iclusig 45mg² :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
5'nucleotidase increased | Uncommon |
Abdominal bloating (Meteorism) | Common |
Abdominal discomfort | Common |
Abdominal pain | Very Common |
Acute coronary syndrome | Common |
Alopecia | Common |
ALT increased | Very Common |
Amylase increased | Common |
Anaemia | Very Common |
Angina pectoris | Common |
Arteriospasm coronary | Uncommon |
Artery dissection | Common |
Arthralgia (Pain joint) (Joint ache) | Very Common |
AST increased | Very Common |
Asthenia | Very Common |
Atrial fibrillation | Common |
Atrial flutter | Common |
Back pain | Very Common |
Blood bilirubin increased | Common |
Bone pain | Very Common |
Cardiac discomfort | Uncommon |
Cardiac failure | Common |
Cellulitis | Common |
Cephalea | Very Common |
Cerebral artery stenosis | Uncommon |
Cerebral haemorrhage | Uncommon |
Cerebral infarction | Common |
Cerebrovascular accident | Common |
Chills | Common |
Congestive heart failure | Common |
Conjunctivitis | Common |
Constipation | Very Common |
Coronary artery disorder | Common |
Cough | Very Common |
Decreased appetite | Very Common |
Deep vein thrombosis | Common |
Dehydration | Common |
Dermatitis exfoliative | Common |
Diarrhoea (Diarrhea) | Very Common |
Dry eye | Common |
Dry mouth (Xerostomia) | Common |
Dry skin | Very Common |
Dyspepsia | Common |
Dysphonia | Common |
Dyspnoea (dyspnea) | Very Common |
Ecchymosis | Common |
Ejection fraction decreased | Common |
Embolism venous | Uncommon |
Epistaxis (Nasal bleeding) | Common |
Erectile dysfunction | Common |
Erythema | Common |
Exfoliative rash | Common |
Eyelid oedema | Common |
Face oedema | Common |
Fatigue | Very Common |
Febrile neutropenia (Neutropenic fever) | Common |
Flu-like syndrome | Common |
Fluid retention | Common |
Flushing | Common |
Folliculitis | Common |
Gamma-GT increased | Common |
Gastric haemorrhage | Common |
Gastrooesophageal reflux disease | Common |
Haemorrhage intracranial | Uncommon |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Uncommon |
Hepatotoxicity (liver toxicity) | Uncommon |
Hot flush | Common |
Hyperaesthesia | Common |
Hyperglycaemia | Common |
Hyperhidrosis | Common |
Hyperkeratosis | Common |
Hypertension | Very Common |
Hypertensive crisis | Uncommon |
Hypertriglyceridaemia | Common |
Hyperuricaemia | Common |
Hypocalcaemia | Common |
Hypoesthesia | Common |
Hypokalaemia | Common |
Hyponatraemia (Hyponatremia) | Common |
Hypophosphataemia | Common |
Hypothyroidism | Very Common |
Insomnia | Very Common |
Intermittent claudication | Common |
Ischaemic cardiomyopathy | Uncommon |
Jaundice | Uncommon |
Left ventricular dysfunction | Uncommon |
Lethargy | Common |
Leucopenia (Leukopenia) | Common |
Lightheadedness | Very Common |
Lipase increased | Very Common |
Lymphocyte count decreased | Common |
Mass | Common |
Migraine | Common |
Muscle spasms | Very Common |
Musculoskeletal chest pain | Common |
Musculoskeletal pain | Common |
Myalgia | Very Common |
Myocardial infarction | Common |
Myocardial ischaemia | Uncommon |
Nausea | Very Common |
Neck pain | Common |
Neuropathy peripheral | Common |
Neutropenia | Very Common |
Night sweats | Common |
Non-cardiac chest pain | Common |
Oedema peripheral | Very Common |
Pain | Very Common |
Pain in extremity (Pain in limb) | Very Common |
Pain of skin | Common |
Pancreatitis | Common |
Pancytopenia | Common |
Paraesthesia (paresthesia) | Common |
Pericardial effusion | Common |
Periorbital oedema | Common |
Peripheral arterial occlusive disease | Common |
Peripheral artery stenosis | Common |
Peripheral ischaemia | Common |
Petechiae | Common |
Phosphatase alkaline increased | Common |
Pleural effusion | Common |
Pneumonia | Common |
Poor peripheral circulation | Uncommon |
Pruritus | Common |
Pulmonary embolism | Common |
Pulmonary hypertension | Common |
Pyrexia | Very Common |
Rash pruritic | Common |
Renal artery stenosis | Uncommon |
Retinal artery occlusion | Uncommon |
Retinal vein occlusion | Uncommon |
Retinal vein thrombosis | Uncommon |
Right ventricular dysfunction | Uncommon |
Septicemia | Common |
Skin exfoliation (Flaking skin) | Common |
Skin hyperpigmentation | Common |
Skin rash | Very Common |
Splenic infarction | Uncommon |
Stomatitis | Common |
Thrombocytopenia (Thrombopenia) | Very Common |
Transient ischaemic attack | Common |
Tumour lysis syndrome | Uncommon |
Upper respiratory tract infection | Very Common |
Venous thrombosis | Uncommon |
Vision blurred | Common |
Visual impairment | Uncommon |
Vomiting | Very Common |
Weight decreased (Weight loss) | Common |
Iclusig 45mg² :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Iclusig 45mg² MoH 11587 :
Form | Tablet, Film-Coated |
Packaging | Plastic Bottle |
Package Size | Box of 30 |
Strength | 45mg |
Public Price | 7408556 L.L. |
Stratum | E2 |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 8322/1 |
Submission date | 2022 |
Registration Year | 13/06/2024 |
Price Comparison
● Country: | Denmark | |
● Package Size: | 30 | |
● Public Price: | 72051.75 DKK | ( 934,943,508.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 2401,725 DKK | ( 31,155,376.00 LBP ) |
● Reference: | Danish Medicine Agency | |
● Pricing Date: | 19/05/2021 |
● Country: | Italy | |
● Package Size: | 30 | |
● Public Price: | 8862.55 EUR | ( 858,568,393.80 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 295,4183 EUR | ( 28,578,420.00 LBP ) |
● Pricing Date: | 17/12/2019 |
● Country: | Oman | |
● Package Size: | 1x30 | |
● Public Price: | 3624.44 OMR | ( 836,281,538.96 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 120,8147 OMR | ( 27,688,080.00 LBP ) |
● Pricing Date: | 19/02/2021 |
● Country: | Abu Dhabi | |
● Package Size: | 30 | |
● Public Price: | 33830.5 AED | ( 817,378,710.50 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 1127,6833 AED | ( 27,229,447.00 LBP ) |
● Pricing Date: | 27/01/2021 |
● Country: | Bahrain | |
● Package Size: | 30 | |
● Public Price: | 3059.59 BHD | ( 727,368,569.06 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 101,9863 BHD | ( 24,011,134.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 09/02/2021 |
● Country: | Finland | |
● Package Size: | 30 | |
● Public Price: | 6880.45 EUR | ( 666,550,474.20 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 229,3483 EUR | ( 22,184,604.00 LBP ) |
● Reference: | Kela | |
● Pricing Date: | 22/04/2021 |
● Country: | The Netherlands | |
● Package Size: | 30 | |
● Public Price: | 6479.01 EUR | ( 627,660,572.76 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 215,967 EUR | ( 20,828,340.00 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 |
● Country: | Ireland | |
● Package Size: | 30 | |
● Public Price: | 6426 EUR | ( 622,525,176.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 214,2 EUR | ( 20,731,464.00 LBP ) |
● Pricing Date: | 08/10/2020 |
● Country: | Cyprus | |
● Package Size: | 30 TABS | |
● Public Price: | 6152.79 EUR | ( 596,057,684.04 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 205,093 EUR | ( 19,859,580.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 24/03/2021 |
● Country: | UK | |
● Package Size: | 30 | |
● Public Price: | 5050 GBP | ( 573,927,450.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 168,3333 GBP | ( 19,093,032.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 |
● Country: | Norway | |
● Package Size: | 30 | |
● Public Price: | 68264.7 NOK | ( 553,217,128.80 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 2275,49 NOK | ( 18,436,600.00 LBP ) |
● Reference: | Norwegian Medicine Agency | |
● Pricing Date: | 01/04/2020 |
● Country: | Sweden | |
● Package Size: | 30 | |
● Public Price: | 64746.25 SEK | ( 544,386,470.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 2158,2083 SEK | ( 18,144,464.00 LBP ) |
● Pricing Date: | 23/04/2020 |
● Country: | Greece | |
● Package Size: | 30 | |
● Public Price: | 5480.51 EUR | ( 530,929,886.76 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 182,6837 EUR | ( 17,631,432.00 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 25/02/2021 |
● Country: | Belgium | |
● Package Size: | 30 | |
● Public Price: | 5298 EUR | ( 513,249,048.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 176,6 EUR | ( 17,050,176.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 02/12/2020 |
● Country: | France | |
● Package Size: | 30 | |
● Public Price: | 4696.75 EUR | ( 455,002,353.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 156,5583 EUR | ( 15,112,656.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 |
● Country: | Lebanon | |
● Form: | Tablet, Film-Coated | |
● Package Size: | Box of 30 | |
● Public Price: | 7408556 LBP | ( 7,408,556.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 246951,87 LBP | ( 246,951.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | Spain |
● Package Size: | 30 |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios |
● Pricing Date: | 06/05/2021 |
Note
You have to register to view this info
Drop File